The U.S. Food and Drug Administration (FDA) has caused an unnecessary scare about some pain relievers by adding a warning to drugs that are safe, says Curt Furberg, M.D., Ph.D., from Wake Forest University School of Medicine. At the same time, he says the agency has failed to recognize the harm of a pain reliever that should be taken off the market. [click link for full article]

From the moment her mom walks in the room and begins taking the bloody bandages off, Ariel Stussy screams. She hits, kicks and flails her arms, trying to make her make her mom stop. Stop Youre hurting me, she screams. While Tena Riste is inflicting pain on her 6-year-old daughter, its a necessary pain. Ariel Stussy is undergoing burn care, a treatment aimed at helping heal the wounds she suffered ...

Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has approved an update to the ORENCIA® (abatacept) product labeling regarding the progression of structural joint damage -- an important measure in the treatment of rheumatoid arthritis (RA). [click link for full article]

The Food and Drug Administration yesterday rejected Merck & Co.'s new Vioxx-like painkiller because of some of the same heart concerns that pushed the blockbuster from the market.

A multimillionaire, Gov. Corzine will spare taxpayers a hefty tab and use his own money to pay for his medical treatment following an automobile crash 15 days ago, a spokesman said Friday.

Merck & Co.'s painkiller Arcoxia has been rejected by U.S. regulators because the arthritis drug has some of the same risks of heart attacks and strokes as the withdrawn medicine Vioxx.

Over-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's disease, according to a study published April 25, 2007, in the online edition of Neurology®, the scientific journal of the American Academy of Neurology. [click link for full article]

Of The TRENTON (AP) -- Multimillionaire Gov. Jon S. Corzine will spare taxpayers a hefty tab and use his own money to pay for his medical treatment following an automobile crash 15 days ago, a spokesman said yesterday.

A prominent pain doctor was convicted yesterday for the second time of trafficking in narcotics, handing prosecutors another victory in a nationwide debate over the prescribing of dangerous narcotics to patients who may abuse or sell the medication.

Neuromed Pharmaceuticals has licensed from Alza Corporation the US rights to Oros Hydromorphone, an extended release pain drug in phase III clinical development.